Evis Harja
- Clinical Biochemistry top 0.2%
- Advanced Glycation End Products research 9
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
- Immunology top 10%
- Atherosclerosis and Cardiovascular Diseases 2
- Periodontics top 5%
- Nephrology top 5%
-
- Protein Kinase Regulation and GTPase Signaling 3
- S100 Proteins and Annexins 3
- Angiogenesis and VEGF in Cancer 2
-
- Adipokines, Inflammation, and Metabolic Diseases 2
-
- Pulmonary Hypertension Research and Treatments 2
- Co-authors
- Ann Marie SchmidtBarry I. HudsonAnastasia Z. KaleaYan LüShi Fang YanLoredana BucciarelliMaria ArrieroMaría del Mar Arriero
- Journals
- Atherosclerosis (3 papers)The FASEB Journal (3 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United StatesAustriaUnited Kingdom
In The Last Decade
Evis Harja
19 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 91
- Clinical Biochemistry 1.1k
- Endocrinology, Diabetes and Metabolism 424
- Immunology 369
- Periodontics 81
- Nephrology 94
Countries citing papers authored by Evis Harja
This map shows the geographic impact of Evis Harja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evis Harja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evis Harja more than expected).
Fields of papers citing papers by Evis Harja
This network shows the impact of papers produced by Evis Harja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evis Harja. The network helps show where Evis Harja may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Evis Harja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 27 | |
| 2 | 2016 | 31 | |
| 3 | 2014 | 1 | |
| 4 | 2013 | 24 | |
| 5 | 2010 | 36 | |
| 6 | 2010 | 12 | |
| 7 | 2008 | 299 | |
| 8 | 2008 | 305 | |
| 9 | 2008 | 29 | |
| 10 | 2008 | 62 | |
| 11 | 2007 | 97 | |
| 12 | 2007 | 308 | |
| 13 | 2006 | 61 | |
| 14 | 2006 | 102 | |
| 15 | 2006 | 0 | |
| 16 | 2006 | 205 | |
| 17 | 2005 | 35 | |
| 18 | 2005 | 185 | |
| 19 | 2005 | 21 | |
| 20 | 2003 | 125 |
About Evis Harja
Evis Harja is a scholar working on Clinical Biochemistry, Immunology and Allergy, Endocrinology, Diabetes and Metabolism, Periodontics and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 2.0k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (9 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), S100 Proteins and Annexins (3 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Pulmonary Hypertension Research and Treatments (2 papers). The work is most often cited by research in Clinical Biochemistry (1.1k citations), Endocrinology, Diabetes and Metabolism (424 citations), Immunology (369 citations), Periodontics (81 citations) and Nephrology (94 citations). Evis Harja has collaborated with scholars based in United States, Austria and United Kingdom. Frequent co-authors include Ann Marie Schmidt, Barry I. Hudson, Anastasia Z. Kalea, Yan Lü, Shi Fang Yan, Loredana Bucciarelli, Maria Arriero, María del Mar Arriero, Éric Boulanger and Vivette D. D’Agati. Their work appears in journals such as Atherosclerosis, The FASEB Journal, Journal of Biological Chemistry, Circulation Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.